Emergent BioSolutions Inc. (EBS) › Shares OutstandingEmergent BioSolutions Inc. (EBS) — Shares OutstandingAnnual figures by period end, from SEC filings.2010-12-31: 35.01M2011-12-31: 36.00M2012-12-31: 35.87M2013-12-31: 36.62M2014-12-31: 37.71M2015-12-31: 39.41M2016-12-31: 40.57M2017-12-31: 49.40M2018-12-31: 51.20M2019-12-31: 51.70M2020-12-31: 53.10M2021-12-31: 51.30M2022-12-31: 50.10M2023-12-31: 52.20M2024-12-31: 54.30M2025-12-31: 52.10M52.10M2010-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3152.10M-4.1%2026-02-27Balance as of period end2024-12-3154.30M+4.0%2026-02-27Balance as of period end2023-12-3152.20M+4.2%2025-03-04Balance as of period end2022-12-3150.10M-2.3%2024-03-08Balance as of period end2021-12-3151.30M-3.4%2023-12-11Balance as of period end2020-12-3153.10M+2.7%2022-02-25Balance as of period end2019-12-3151.70M+1.0%2021-02-19Balance as of period end2018-12-3151.20M+3.6%2020-02-25Balance as of period end2017-12-3149.40M+21.8%2019-02-22Balance as of period end2016-12-3140.57M+3.0%2018-02-23Balance as of period end2015-12-3139.41M+4.5%2017-02-28Balance as of period end2014-12-3137.71M+3.0%2016-02-29Balance as of period end2013-12-3136.62M+2.1%2015-03-09Balance as of period end2012-12-3135.87M-0.4%2014-03-10Balance as of period end2011-12-3136.00M+2.8%2013-03-08Balance as of period end2010-12-3135.01M—2012-03-09Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)